Biotech
-
Safety and Tolerability of Anti-Coronavirus Drug Candidates Observed in an Animal Model Further Advances NanoViricides’ SARS-CoV-2 Therapeutics Program
Shelton, Connecticut — July 8, 2020 — NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a leader in the development of highly…
Read More » -
Pressure Bio: The $3.5 Million Order For Hand Sanitizers Could Really Increase The Momentum Of This Stock
Pressure Bio (OTCPK:PBIO) is one of the most promising microcaps that has been covered by us over the past few…
Read More » -
$3,500,000 Initial Order for FDA-Registered, Premium Hand Sanitizer Catapults SkinScience Labs, a Pending Accretive Acquisition of Pressure BioSciences, Into the Multi-Billion Dollar Hand Sanitizer Market
SkinScience Labs, Creator of Award-Winning Dr. Denese Skin Care & Anti-Aging Product Lines, Enters Hand Sanitizer Market with Proprietary Formula…
Read More » -
NanoViricides: Drug Candidates Show Fantastic Results In Animal Model
In our earlier pieces, we have provided an in-depth coverage of the promising biopharma smallcap NanoViricides Inc. (NYSE American: NNVC)…
Read More » -
Pressure BioSciences Announces Launch of FDA-Registered Hand Sanitizer as First Product Developed Through Pending Merger Partners
South Easton, MA, May 14, 2020 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the…
Read More » -
Pressure BioSciences, Through Cannaworx, Inc., Announces Letter of Intent to Acquire SkinScience Labs, Inc.
South Easton, MA, April 30, 2020 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the…
Read More » -
U.S. Senator Richard Blumenthal Visited NanoViricides Inc. for Update on Coronavirus Drug Development Efforts
SHELTON, CONNECTICUT — April 6, 2020 — NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a leader in the development of…
Read More » -
Nemaura Medical to Launch their non-invasive continuous glucose monitor in the US market under the Wellness Category
Given some recent news, we think investors should take the time to research Nemaura Medical Inc. (NASDAQ: NMRD)
Read More » -
Nemaura To Prepare for Launch of sugarBEAT CGM In the U.S. Following FDA Feedback
Loughborough, England, March [18], 2020 — Nemaura Medical Inc (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused…
Read More » -
Parallax Diagnostics Announces Intent to Develop a Rapid Screening Test for COVID-19 on its Patented FDA 510(K) Approved Diagnostic Platform
New York, NY – March 11, 2020 – Parallax Health Sciences, Inc.(OTCQB: PRLX) (”Parallax” or the ”Company”), an outcome-driven connected healthcare…
Read More »
